Respiratory/Pulmonary

Keeping asthma at bay

NIH has updated its guidelines on asthma diagnosis and treatment. Learn how to help your asthma patients lead fuller lives.

FDA approves new drug for COPD

The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD). Read more…

FDA approves new device for asthma

On April 27, the U.S. Food and Drug Administration approved the first medical device that uses radiofrequency energy to treat severe and persistent asthma…

USDA new safety requirements for beta-agonists

The U.S. Food and Drug Administration has new safety requirements for long-acting beta-agonists used to treat asthma. Read the requirements at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm.,/p>

Keeping asthma at bay

NIH has updated its guidelines on asthma diagnosis and treatment. Learn how to help your asthma patients lead fuller lives.

FDA approves new drug for COPD

The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD).…

FDA approves new device for asthma

On April 27, the U.S. Food and Drug Administration approved the first medical device that uses radiofrequency energy to treat severe and…

USDA new safety requirements for beta-agonists

The U.S. Food and Drug Administration has new safety requirements for long-acting beta-agonists used to treat asthma. Read the requirements at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm.,/p>

Poll

Preferred way to get content

What is your preferred way to consume healthcare content?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.